1
|
Li L, Li SY, Zhong X, Ren J, Tian X, Tuerxun M, Xie C, Li F, Zheng A, Aini P, Yasen M, Wang H, Zou X. SERPINE2 rs16865421 polymorphism is associated with a lower risk of chronic obstructive pulmonary disease in the Uygur population: A case-control study. J Gene Med 2019; 21:e3106. [PMID: 31215134 DOI: 10.1002/jgm.3106] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2019] [Revised: 05/12/2019] [Accepted: 06/05/2019] [Indexed: 01/19/2023] Open
Abstract
BACKGROUND The present study aimed to investigate the relationship between seven polymorphisms of the serine protease inhibitor-2 (SERPINE2) gene and the risk of chronic obstructive pulmonary disease (COPD) in the Uygur population via a case-control study. METHODS In total, 440 Uygur patients with COPD were included in the patient group and 384 healthy individuals were recruited in the matched control group. Data on demographic variables, smoking status, occupational dust exposure history and living conditions were collected. Polymorphism analysis was performed for seven loci of the SERPINE2 gene by mass spectrometry. RESULTS The genotype distribution of rs16865421 showed a significant difference between the patient and control groups (p < 0.05). Participants carrying the rs16865421-AG heterozygous mutant genotype had a lower risk of COPD compared to those with the rs16865421-A allele (odds ratio = 0.68, 95% confidence interval = 0.47-0.98, p = 0.041). However, no such association was found for rs1438831, rs6734100, rs6748795, rs7583463, rs840088 and rs975278. No significant interaction was observed between the genotypes and risk factors. CONCLUSIONS Polymorphisms of rs16865421-AG carried by the Uygur population may be protective against COPD.
Collapse
Affiliation(s)
- Li Li
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Shi Yue Li
- Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangdong, Guangzhou, Guangdong, China
| | - Xuemei Zhong
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Jie Ren
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Xuwei Tian
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Maimaitiaili Tuerxun
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Chengxin Xie
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Feifei Li
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Aifang Zheng
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Paierda Aini
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Mukeremu Yasen
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Huaizhen Wang
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| | - Xiaoguang Zou
- Department of Respiratory and Critical Care Medicine, First People's Hospital of Kashgar, Xinjiang, Kashgar, Xinjiang, China
| |
Collapse
|